DOSSIER · 13F-HR · Q2 2026

Kalehua Capital Management LLC

$313M in tracked AUM across 49 positions as of Q2 2026.

KC
CIK 0002106181 · last filed Jun 30, 2026
Total AUM
$313M
as of Q2 2026
Holdings
49
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Kalehua Capital Management LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
MANE
Veradermics Inc
$36M291K11.4%
02
XFOR
X4 Pharmaceuticals Inc
$35M7.4M11.1%
03
BOXX
EA SERIES TRUST
$26M226K8.4%
04
CMPS
Compass Pathways Plc
$23M1.6M7.4%
05
SRZN
Surrozen Inc
$20M770K6.4%
06
ACRS
Aclaris Therapeutics Inc
$19M3.7M6.2%
07
SION
Sionna Therapeutics Inc
$17M394K5.5%
08
IKT
Inhibikase Therapeutics Inc
$16M7.6M4.9%
09
N69605108
Pharvaris NV
$14M398K4.4%
10
KPTI
Karyopharm Therapeutics Inc
$13M1.4M4.3%

Filing history

2026Q2Jun 30
$313M 20.6%
49 positionsView →
2026Q1Mar 31
$260M 157.1%
50 positionsView →
2025Q4Dec 31
$101M
19 positionsView →